ARRONAX operates the world-wide only C70XP cyclotron, a high-intensity multi-particle cyclotron that supplies proton beams up to 70 MeV and 350 μA as well as deuteron beams up to 35 MeV and alpha particle beams of 68 MeV. Appropriate targetry and radiochemical separation is developed in-house. As one of few facilities worldwide, ARRONAX holds an FDA certification for Sr-82 as an active pharmaceutical ingredient.
ARRONAX is the only European producer of Sr-82 and the leading producer of Cu-64 and At-211 in France. Cu-64 is supplied in GMP quality for clinical trials.
As Day-1 radionuclides, ARRONAX can provide Cu-64 as Cu-64Cl2 or Cu-64-ATSM in GMP quality approved for human use. Further, Sc-44, Cu-67 and At-211 can be supplied for chemistry studies or preclinical experiments respectively (depending on required activities).